Inventor
Xiao Xu
Inventor
San Diego, CA, US
Overview
Patents· 24 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
A61KPreparations for medical, dental or toiletry purposes19%
C07DHeterocyclic compounds17%
H04LTransmission of digital information, e.g. telegraphic communication10%
G06FElectric digital data processing7%
C07KPeptides5%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms5%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
G06QInformation and communication technology [ict] specially adapted for administrative, commercial, financial, managerial or supervisory purposes3%
H04WWireless communication networks3%
PatentTitleYear
10,810,362Page-based incident correlation for network applications202010,799,504Heterocyclic compounds and uses as anticancer agents202010,686,627Distributed virtual gateway appliance202010,596,174Pyrrolopyrimidine compounds as inhibitors of protein kinases202010,562,918Heterocyclic compounds and uses thereof202010,558,635Traffic data stream aggregate query method and system202010,533,011Pharmaceutical salts, physical forms, and compositions of pyrrolopyrimidine kinase inhibitors, and methods of making same202010,449,196EGFR modulators and uses thereof201910,277,423Distributed virtual gateway appliance20199,920,074'Heterocyclic compounds and uses thereof'20189,819,758'Remote debugging into mobile web applications across devices'20179,806,911'Distributed virtual gateway appliance'20179,763,949'EGFR modulators and uses thereof'20179,684,886'Cross-domain business mashup integration'20179,623,027'EGFR modulators and uses thereof'20179,586,965'Pyrrolo[2,3-d]pyrimidine compounds as inhibitors of protein kinases'20179,584,619'Business web applications lifecycle management with multi-tasking ability'20179,464,089'Heterocyclic compounds and uses thereof'20169,384,284'Value-added usage of process-oriented extension fields in business mashups'20169,107,905'Modulators of Candida hyphal morphogenesis and uses thereof'20159,034,885'EGFR modulators and uses thereof'20158,889,134'Modulators of Candida hyphal morphogenesis and uses thereof'20148,383,110'Modulators of Candida hyphal morphogenesis and uses thereof'20137,622,507'Substituted organosulfur compounds and methods of using thereof'2009Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2009–2020Patents assigned to ACEA BIOSCIENCES INC (10)· patent assignee history
2009–2020Based in San Diego, CA, US· patent location history
2013–2015Patents assigned to AGENCY SCIENCE TECH & RES (3)· patent assignee history
2013–2015Based in Singapore, SG· patent location history
2016–2020Patents assigned to SAP SE (5)· patent assignee history
2016–2020Based in Wujiang, CN· patent location history
2017–2020Patents assigned to IBM (3)· patent assignee history
2017–2020Based in Shanghai, CN· patent location history
2019–2020Patents assigned to ACEA THERAPEUTICS INC (5)· patent assignee history
2020Based in Jiangsu, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ACEA BIOSCIENCES INC | 10 | 2009–2020 |
| ACEA THERAPEUTICS INC | 5 | 2019–2020 |
| SAP SE | 5 | 2016–2020 |
| AGENCY SCIENCE TECH & RES | 3 | 2013–2015 |
| IBM | 3 | 2017–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Diego, California, US | 12 | 2009–2020 |
| Shanghai, CN | 5 | 2017–2020 |
| Wujiang, CN | 3 | 2016–2020 |
| Singapore, SG | 3 | 2013–2015 |
| Jiangsu, CN | 1 | 2020 |